Teva Pharmaceutical Industries reported its second-quarter 2025 financial results on Wednesday, reflecting a mixed performance amid continued shifts in its portfolio strategy. CEO Richard Francis speaks with Bloomberg's Scarlet Fu and Katie Griefeld.

Nobel Laureate in Economics and Professor of Economics Paul Krugman Talks SCOTUS
07:09

California Attorney General Rob Bonta Talks Tariff Ruling
06:31

Middle East Geoeconomics Lead for Bloomberg Economics, Dina Esfandiary, Talks US Military, Middle East Tensions
07:38